Medical Pharmacology Chapter 33-34:  Anticancer Drugs

Previous Page Next Page

Section Table of Contents

Site Table of Contents

Previous Page Next Page

Section Table of Contents

Site Table of Contents

  1. Wellstein A Giaccone G Atkins MB Sausville Chapter 66:  Cytotoxic Drugs in Goodman & Gilman's:  The Pharmacological Basis of Therapeutics, 13e, Brunton LL Hilal-Dandan R Knollmann BC, eds) 2018.

  2. Sausville EA Longo DL Chapter 103e Principles of Cancer Treatment, in Harrison's Online   (Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo,  J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 19th edition, The McGraw-Hill Companies, Inc. 2015.

  3. Chu E  Cancer Chemotherapy Chapter 54 in Basic & Clinical Pharmacology, 14 e (Katzung BG The McGraw-Hill Companies, 2018 (on-line edition)

  4. Tew KD Chapter 17:  Alkylating Agents  in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  5. Collins JM Cancer Pharmacology Chapter 29 in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

  6. Roche VF Cancer and Chemotherapy Chapter 37: Therapeutic Classes of Anticancer Drugs-Nitrogen Mustards and Aziridine-Mediated Alkylators. in Foye's Priniciples of Medicinal Chemistry (Lemke TL Williams DA, eds; associate eds, Roche VF Zito SW) 7e Lippinoctt, Williams & Wilkins, a Wolters Kluwer business, 2013.

  7. O'Dwyer PJ Calvert AH   Chapter 18:  Platinum Analogs in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  8. Saif MW Chu E Chapter 19 Antimetabolites in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  9. Methotrexate:  Wikipedia entry, https://en.wikipedia.org/wiki/Methotrexate .

  10. Sodani K Patel A Kathawala RJ Chen Z-S Multidrug resistance associated proteins in multidrug resistance Clin J Cancer 2012 Feb:  3(12): 58-72. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777468/

References

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.